{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:22Z","timestamp":1760028562574},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.4065\/mcp.2009.0314","type":"journal-article","created":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T19:04:28Z","timestamp":1264791868000},"page":"165-171","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Use of Drug-Eluting Stents in Patients With Coronary Artery Disease and Renal Insufficiency"],"prefix":"10.4065","volume":"85","author":[{"given":"Ayman A.","family":"El-Menyar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jassim","family":"Al Suwaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.4065\/mcp.2009.0314_bib1","first-page":"1786","article-title":"Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial","volume":"44","author":"Best","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijcard.2008.04.028","article-title":"Impact of moderate or severe renal insufficiency on long-term outcomes in patients undergoing drug-eluting stent based coronary intervention","volume":"136","author":"Zhang","year":"2009","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.4065\/mcp.2009.0314_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjcard.2004.08.089","article-title":"Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents","volume":"95","author":"Lemos","year":"2005","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.4065\/mcp.2009.0314_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ahj.2005.01.032","article-title":"Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial","volume":"150","author":"Halkin","year":"2005","journal-title":"Am Heart J"},{"issue":"14","key":"10.4065\/mcp.2009.0314_bib5","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/00029330-200607020-00007","article-title":"Long term clinical outcomes in patients with moderate renal insufficiency undergoing stent based percutaneous coronary intervention","volume":"119","author":"Zhang","year":"2006","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.4065\/mcp.2009.0314_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1445-5994.2006.01012.x","article-title":"Morbidity, mortality and economic burden of renal impairment in cardiac intensive care","volume":"36","author":"Chew","year":"2006","journal-title":"Intern Med J"},{"issue":"5","key":"10.4065\/mcp.2009.0314_bib7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0735-1097(02)02956-X","article-title":"Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb\/IIIa inhibitors","volume":"41","author":"Freeman","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.4065\/mcp.2009.0314_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/0003-4819-134-8-200104170-00007","article-title":"Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial","volume":"134","author":"Mann","year":"2001","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.4065\/mcp.2009.0314_bib9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.amjcard.2007.11.009","article-title":"Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention","volume":"101","author":"Osten","year":"2008","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.4065\/mcp.2009.0314_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.4065\/mcp.2009.0314_bib11","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","article-title":"Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction","volume":"108","author":"Sadeghi","year":"2003","journal-title":"Circulation"},{"issue":"13","key":"10.4065\/mcp.2009.0314_bib12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"11","key":"10.4065\/mcp.2009.0314_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ahj.2005.03.018","article-title":"Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention","volume":"151","author":"Blackman","year":"2006","journal-title":"Am Heart J"},{"issue":"2","key":"10.4065\/mcp.2009.0314_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000111829","article-title":"Chronic kidney disease is associated with angiographic coronary artery disease","volume":"28","author":"Chonchol","year":"2008","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.4065\/mcp.2009.0314_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/ndt\/gfl564","article-title":"Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients","volume":"22","author":"Kra\u015bniak","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000046036","article-title":"Long-term outcome after percutaneous transluminal coronary angioplasty in patients with chronic renal failure with and without diabetic nephropathy","volume":"89","author":"Matzkies","year":"2001","journal-title":"Nephron"},{"issue":"10","key":"10.4065\/mcp.2009.0314_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2169\/internalmedicine.47.0932","article-title":"Impact of impaired renal function and diabetes on long-term prognosis in patients undergoing primary angioplasty for acute coronary syndrome","volume":"47","author":"Goto","year":"2008","journal-title":"Intern Med"},{"issue":"24","key":"10.4065\/mcp.2009.0314_bib19","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/01.CIR.102.24.2966","article-title":"Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?","volume":"102","author":"Rubenstein","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.4065\/mcp.2009.0314_bib20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","article-title":"Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes","volume":"106","author":"Al Suwaidi","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.4065\/mcp.2009.0314_bib21","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"10.4065\/mcp.2009.0314_bib22","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.ehj.2003.08.013","article-title":"Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention","volume":"24","author":"Lu","year":"2003","journal-title":"Eur Heart J"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ccd.10103","article-title":"Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure","volume":"55","author":"Gruberg","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.4065\/mcp.2009.0314_bib24","first-page":"273","article-title":"Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients","volume":"18","author":"Hassani","year":"2006","journal-title":"J Invasive Cardiol"},{"issue":"7","key":"10.4065\/mcp.2009.0314_bib25","first-page":"1343","article-title":"The renal patient with coronary artery disease: current concepts and dilemmas. [published correction appears in J Am Coll Cardiol. 2004;44(11):2283]","volume":"44","author":"Gupta","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.4065\/mcp.2009.0314_bib26","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.105.607390","article-title":"Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"114","author":"Rajagopalan","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1681\/ASN.V5136","article-title":"Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease","volume":"5","author":"Gawaz","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.4065\/mcp.2009.0314_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1525-139X.2006.00179.x","article-title":"Platelet dysfunction and end-stage renal disease","volume":"19","author":"Kaw","year":"2006","journal-title":"Semin Dial"},{"issue":"3","key":"10.4065\/mcp.2009.0314_bib29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0038-1650576","article-title":"Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis","volume":"76","author":"Mezzano","year":"1996","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.4065\/mcp.2009.0314_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ahj.2007.10.046","article-title":"The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial","volume":"155","author":"Best","year":"2008","journal-title":"Am Heart J"},{"issue":"7","key":"10.4065\/mcp.2009.0314_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"issue":"7637","key":"10.4065\/mcp.2009.0314_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.4065\/mcp.2009.0314_bib33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/0953710021000024000","article-title":"Phospholipase A2 activity in platelets of patients with uremia","volume":"13","author":"Vecino","year":"2002","journal-title":"Platelets"},{"issue":"2","key":"10.4065\/mcp.2009.0314_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2215\/CJN.00510705","article-title":"Coronary revascularization in diabetic chronic kidney disease\/end-stage renal disease: a nephrologist's perspective","volume":"1","author":"Williams","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.4065\/mcp.2009.0314_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9149(01)02267-6","article-title":"Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab","volume":"89","author":"Frilling","year":"2002","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9149(02)02991-0","article-title":"Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial)","volume":"91","author":"Reddan","year":"2003","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.4065\/mcp.2009.0314_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjcard.2004.11.003","article-title":"Bivalirudin versus heparin and glycoprotein IIb\/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)","volume":"95","author":"Chew","year":"2005","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1253\/circj.72.56","article-title":"Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis","volume":"72","author":"Aoyama","year":"2008","journal-title":"Circ J"},{"issue":"17","key":"10.4065\/mcp.2009.0314_bib39","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1161\/01.CIR.0000035248.71165.EB","article-title":"Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes","volume":"106","author":"Herzog","year":"2002","journal-title":"Circulation"},{"issue":"5-6","key":"10.4065\/mcp.2009.0314_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000090181","article-title":"Percutaneous coronary intervention in patients with end-stage renal disease","volume":"28","author":"Bocksch","year":"2005","journal-title":"Kidney Blood Press Res"},{"issue":"9","key":"10.4065\/mcp.2009.0314_bib41","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.CIR.0000121327.67756.19","article-title":"Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis","volume":"109","author":"Fujii","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.4065\/mcp.2009.0314_bib42","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1253\/circj.71.1525","article-title":"Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients","volume":"71","author":"Ishio","year":"2007","journal-title":"Circ J"},{"issue":"20","key":"10.4065\/mcp.2009.0314_bib43","doi-asserted-by":"crossref","first-page":"e586","DOI":"10.1161\/CIRCULATIONAHA.106.637363","article-title":"Images in cardiovascular medicine: damage to polymer of a sirolimus-eluting stent","volume":"114","author":"Kuriyama","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1253\/jcj.60.27","article-title":"Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty","volume":"60","author":"Tsutsui","year":"1996","journal-title":"Jpn Circ J"},{"issue":"6","key":"10.4065\/mcp.2009.0314_bib45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ccd.21016","article-title":"Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents","volume":"69","author":"Nakazawa","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"10.4065\/mcp.2009.0314_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000169012","article-title":"Cytokine production during hemodialysis: effects of dialytic membrane and complement activation","volume":"16","author":"Lin","year":"1996","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.4065\/mcp.2009.0314_bib47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ccd.21093","article-title":"Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force","volume":"69","author":"Hodgson","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"10.4065\/mcp.2009.0314_bib48","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/CIRCULATIONAHA.105.600155","article-title":"Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents","volume":"113","author":"Kuchulakanti","year":"2006","journal-title":"Circulation"},{"issue":"17","key":"10.4065\/mcp.2009.0314_bib49","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.4065\/mcp.2009.0314_bib50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jacc.2007.04.051","article-title":"Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry","volume":"50","author":"Machecourt","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.4065\/mcp.2009.0314_bib51","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.amjcard.2008.02.058","article-title":"Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry)","volume":"101","author":"Yan","year":"2008","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.4065\/mcp.2009.0314_bib52","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2007.10.057","article-title":"Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos)","volume":"51","author":"de la Torre-Hern\u00e1ndez","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.4065\/mcp.2009.0314_bib53","first-page":"577","article-title":"Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients","volume":"18","author":"Halkin","year":"2006","journal-title":"J Invasive Cardiol"},{"issue":"7","key":"10.4065\/mcp.2009.0314_bib54","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.4065\/mcp.2009.0314_bib55","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jacc.2005.11.092","article-title":"Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings","volume":"47","author":"Kotani","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjcard.2004.08.056","article-title":"Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables","volume":"95","author":"Dangas","year":"2005","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.4065\/mcp.2009.0314_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2007.02.026","article-title":"Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation","volume":"125","author":"Jeong","year":"2008","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.4065\/mcp.2009.0314_bib58","first-page":"331","article-title":"Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease","volume":"19","author":"Mishkel","year":"2007","journal-title":"J Invasive Cardiol"},{"issue":"12","key":"10.4065\/mcp.2009.0314_bib59","first-page":"685","article-title":"Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-year clinical follow-up of a consecutive series of cases","volume":"16","author":"Daemen","year":"2004","journal-title":"J Invasive Cardiol"},{"issue":"6","key":"10.4065\/mcp.2009.0314_bib60","first-page":"331","article-title":"Limitation on efficacy of sirolimus-eluting stent implantation in patients on hemodialysis [in Japanese]","volume":"49","author":"Suzuki","year":"2007","journal-title":"J Cardiol"},{"issue":"9","key":"10.4065\/mcp.2009.0314_bib61","first-page":"405","article-title":"Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization","volume":"18","author":"Das","year":"2006","journal-title":"J Invasive Cardiol"},{"issue":"6","key":"10.4065\/mcp.2009.0314_bib62","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1536\/ihj.48.689","article-title":"Comparison of long-term clinical outcome after sirolimus-eluting stent implantation in patients waith and without hemodialysis","volume":"48","author":"Sasao","year":"2007","journal-title":"Int Heart J"},{"issue":"6","key":"10.4065\/mcp.2009.0314_bib63","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.amjcard.2005.10.018","article-title":"Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents","volume":"97","author":"Kuchulakanti","year":"2006","journal-title":"Am J Cardiol"},{"issue":"14","key":"10.4065\/mcp.2009.0314_bib64","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.4065\/mcp.2009.0314_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.293.2.165","article-title":"Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial","volume":"293","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"issue":"suppl","key":"10.4065\/mcp.2009.0314_bib66","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.3346\/jkms.2009.24.S1.S87","article-title":"The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography","volume":"24","author":"Na","year":"2009","journal-title":"J Korean Med Sci"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961160390X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961160390X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T14:27:03Z","timestamp":1675866423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961160390X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S002561961160390X"],"URL":"https:\/\/doi.org\/10.4065\/mcp.2009.0314","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Drug-Eluting Stents in Patients With Coronary Artery Disease and Renal Insufficiency","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4065\/mcp.2009.0314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}